Genotypic drug resistance during HIV-1 primary infection in France (1996–1999): frequency and response to treatment
- 1 March 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 16 (5), 793-796
- https://doi.org/10.1097/00002030-200203290-00017
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Retracing the Evolutionary Pathways of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors: Virus Fitness in the Absence and in the Presence of DrugJournal of Virology, 2000
- Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infectionJournal of Medical Virology, 2000
- Weak anti-HIV CD8+ T-cell effector activity in HIV primary infectionJCI Insight, 1999
- Highly Active Antiretroviral Treatment Initiated Early in the Course of Symptomatic Primary HIV‐1 Infection: Results of the ANRS 053 TrialThe Journal of Infectious Diseases, 1999
- HIV-1 Drug Resistance in Newly Infected IndividualsJama-Journal Of The American Medical Association, 1999
- Reduced Antiretroviral Drug Susceptibility Among Patients With Primary HIV InfectionJama-Journal Of The American Medical Association, 1999
- Transmission of antiretroviral-drug-resistant HIV-1 variantsThe Lancet, 1999
- Prevalence of primary HIV drug resistance among seroconverters during an explosive outbreak of HIV infection among injecting drug usersAIDS, 1999
- Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1993